Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference29 articles.
1. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI;McManus;Am. J. Med.,2017
2. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction;Grines;N. Engl. J. Med.,1993
3. Incidence and management of restenosis after treatment of unprotected left Main disease with second-generation drug-eluting stents (from failure in left main study with 2nd Generation Stents-Cardiogroup III Study);D'Ascenzo;Am. J. Cardiol.,2017
4. Rotational atherectomy in very long lesions: results for the ROTATE registry;Iannaccone;Catheter. Cardiovasc. Interv.,2016
5. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationThe Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC);Steg;Eur. Heart J.,2012
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2023-10
2. Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome;Journal of Clinical Medicine;2023-02-17
3. Association between ticagrelor plasma concentration and bleeding events in Chinese patients with acute coronary syndrome;British Journal of Clinical Pharmacology;2022-06-19
4. In-Hospital Bleeding in Elderly Patients With Acute Coronary Syndrome: Are Potent Antiplatelet Agents Safe?;Angiology;2022-03-29
5. Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial;Journal of Atherosclerosis and Thrombosis;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3